$SNTA Recent Headlines Buy stocks driven by secular

New Post Public Reply Private Reply Replies (0) Message Board

Jun 8, 2014 at 12:22 PM

$SNTA Recent Headlines

Buy stocks driven by secular trends 7:22 a.m. July 10, 2012 - The Trading Deck
Thursday’s top gaining and declining stocks 4:54 p.m. June 28, 2012 - MarketWatch
Synta dives 30% on lung cancer study 11:21 a.m. June 28, 2012 - Val Brickates Kennedy
Friday’s biggest gaining and declining stocks 5:44 p.m. Jan. 6, 2012 - Kate Gibson
Synta tumbles 14% on stock offering 12:47 p.m. Jan. 6, 2012 - Val Brickates Kennedy
Novavax grabs drug-stock spotlight 1:49 p.m. March 1, 2011 - Val Brickates Kennedy
Medicis, PDL lead drug stocks north 12:47 p.m. Feb. 28, 2011 - Val Brickates Kennedy
Synta shares jump on lung cancer drug update 11:41 a.m. Feb. 28, 2011 - Val Brickates Kennedy
Synta rallies as drug stocks slip 1:33 p.m. Feb. 9, 2011 - Val Brickates Kennedy
Synta rallies as drug stocks slip 11:05 a.m. Feb. 9, 2011 - Val Brickates Kennedy
Updates, advisories and surprises 7:31 p.m. Aug. 10, 2010 - MarketWatch
SciClone, Synta lead decliners 3:34 p.m. Aug. 10, 2010 - Val Brickates Kennedy
Synta falls on financial update 10:32 a.m. Aug. 10, 2010 - Val Brickates Kennedy
Javelin shares plunge on U.K. drug recall 4:09 p.m. May 24, 2010 - Val Brickates Kennedy
Big Pharma advances in broader market rally 3:35 p.m. May 10, 2010 - Val Brickates Kennedy
Drug stocks mixed; Angiotech climbs on FDA update 1:52 p.m. Oct. 10, 2007 - Val Brickates Kennedy
GlaxoSmithKline, Synta to develop melanoma treatment 9:00 a.m. Oct. 10, 2007 - Robert Daniel
Synta Pharma IPO falls to $9.42, below $10 price 3:27 p.m. Feb. 6, 2007 - Steve Gelsi
Synta Pharma IPO prices at $10, below $14-$16 range 12:19 p.m. Feb. 6, 2007 - Steve Gelsi

Short Interest is Piling Up in Synta (SNTA) Stock, Time to Panic? - Tale of the Tape 8:57 a.m. May 23, 2014 - Zacks.com
10-Q: SYNTA PHARMACEUTICALS CORP 6:18 a.m. May 8, 2014 - Edgar Online - (EDG = 10Q, 10K)
Speculative But Attractive Biotechs Insiders Are Buying 10:12 a.m. April 21, 2014 - Seeking Alpha
SNTA: Insiders Vs. Shorts 2:33 p.m. April 11, 2014 - TheStreet.com
Synta Pharmaceuticals Corp. (SNTA) Catches Eye: Stock Jumps 9.5% - Tale of the Tape 8:44 a.m. March 21, 2014 - Zacks.com
March Madness: Final Four Investing Bracket 2014 6:36 p.m. March 20, 2014 - Seeking Alpha
Synta Pharma up 26% premarket 8:20 a.m. March 20, 2014 - Seeking Alpha
SNTA: Synta Pharmaceuticals Soars on Breast Cancer Treatment News 7:12 a.m. March 20, 2014 - InvestorPlace.com
7 Stocks That Analysts Want You To Sell 7:41 a.m. March 16, 2014 - 247WallSt.com
Top Analyst Upgrades and Downgrades: AIG, GM, Rite Aid, Synta, Disney and More 7:34 a.m. March 12, 2014 - 247WallSt.com
Synta Pharmaceuticals' Management Discusses Q4 2013 Results - Earnings Call Transcript 2:01 p.m. March 11, 2014 - Seeking Alpha
Synta Pharmaceuticals Corp. Discusses Q3 2013 Results (Webcast) 9:55 a.m. March 11, 2014 - Seeking Alpha
10-K: SYNTA PHARMACEUTICALS CORP 6:09 a.m. March 11, 2014 - Edgar Online - (EDG = 10Q, 10K)
Weakness Seen in Synta Pharmaceuticals (SNTA): Stock Tumbles 13.5% - Tale of the Tape 9:54 a.m. March 6, 2014 - Zacks.com
Synta CEO resigns 5:19 p.m. March 3, 2014 - Seeking Alpha
2 $7 Speculative Biotechs That Are On The Move 10:26 a.m. Feb. 26, 2014 - Seeking Alpha
Synta Pharmaceuticals (SNTA) Catches Eye: Stock Rises 8.9% - Tale of the Tape 10:25 a.m. Feb. 25, 2014 - Zacks.com
Synta anti-cancer platform shows "proof of principle" 10:35 a.m. Feb. 24, 2014 - Seeking Alpha
Four Biotech Stocks Called to Double 9:34 a.m. Feb. 22, 2014 - 247WallSt.com
Two $5 Biotech Stocks Insiders Are Scooping Up 9:41 a.m. Feb. 10, 2014 - Seeking Alpha

Biotech Equities Ahead of Market -- Research on Vertex Pharma, NewLink Genetics, ImmunoGen, and Synta Pharma 7:20 a.m. June 5, 2014 - PR Newswire - PRF
Synta to Present at the Jefferies 2014 Global Healthcare Conference 8:02 a.m. May 29, 2014 - BusinessWire - BZX
Synta Announces Presentations at the 2014 American Society for Clinical Oncology (ASCO) Annual Meeting 8:04 a.m. May 28, 2014 - BusinessWire - BZX
Biotech Stocks Technical Data -- Research on Alnylam Pharma, Regeneron Pharma, Cel-Sci, and Synta Pharma 10:15 a.m. May 13, 2014 - PR Newswire - PRF
Synta Announces Results From Final Analysis of the GALAXY-1 Trial of Ganetespib in NSCLC 7:04 a.m. May 8, 2014 - BusinessWire - BZX
Synta Reports First Quarter 2014 Financial Results and Provides Corporate Update 7:04 a.m. May 8, 2014 - BusinessWire - BZX
Synta to Host Conference Call and Webcast of First Quarter 2014 Financial Results on May 8, 2013 5:01 p.m. April 29, 2014 - BusinessWire - BZX
Synta Pharmaceuticals Enters Into Agreement to Sell $5.0 Million in Common Stock Directly to an Affiliate of Synta Board Member Bruce Kovner 8:03 a.m. April 14, 2014 - BusinessWire - BZX
Acquisitions, Scheduled Earnings Releases, Appointments, Clinical Trials, and Stock Movements - Analyst Notes on Baxter, AcelRx, Synta Pharmaceuticals, Spectranetics, and NuVasive 8:00 a.m. April 11, 2014 - PR Newswire - PRF
Synta Announces Presentations at the 2014 Annual Meeting of the American Association of Cancer Research 7:31 a.m. April 7, 2014 - BusinessWire - BZX
Candidate Selection for Clinical Trials, Financial Results, and Patient Enrollments for Phase I Study - Analyst Notes on Synta, Ziopharm, Aastrom, Agios, and OncoMed 8:00 a.m. March 25, 2014 - PR Newswire - PRF
Synta Announces Positive Interim Results from the ENCHANT-1 Trial of Ganetespib in Metastatic Breast Cancer at the 9th European Breast Cancer Conference 5:45 a.m. March 20, 2014 - BusinessWire - BZX
Coverage of Top Gainers -- Research on Synta Pharma, BG Medicine, Abraxas Petroleum, and xG Technology 8:25 a.m. March 19, 2014 - PR Newswire - PRF
Synta Reports Fourth Quarter and Year-End 2013 Financial Results and Provides Corporate Update 7:04 a.m. March 11, 2014 - BusinessWire - BZX
Synta and QuantumLeap Healthcare Collaborative Announce Selection of Ganetespib for I-SPY 2 TRIAL in Breast Cancer 7:02 a.m. March 11, 2014 - BusinessWire - BZX
Favorable Court Judgments, Stock Price Updates, and Upcoming Investors Conferences - Analyst Notes on Salix, Cerner, Hologic, Covance, and Synta 10:20 a.m. March 6, 2014 - PR Newswire - PRF
Synta Announces Executive Management Changes, Appoints Dr. Paul A. Friedman Director 5:02 p.m. March 3, 2014 - BusinessWire - BZX
Synta to Present on Hsp90-inhibitor Drug Conjugate Platform at the 12th International Congress on Targeted Anticancer Therapies 2:36 p.m. Feb. 28, 2014 - BusinessWire - BZX
Synta to Present at Upcoming Conferences 5:06 p.m. Feb. 27, 2014 - BusinessWire - BZX
Synta to Host Conference Call and Webcast of Fourth Quarter and Year-End 2013 Financial Results on March 11, 2014 5:06 p.m. Feb. 26, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Truss Financial Tackles Home Equity Closing Delays

Truss Financial Group's Bold Move Against Closing Delays In real estate, time is money. Even the most casual market observer could tell you delays can slice through a deal like a hot knife through butter. That's the headache home equity borrowers face, blindsided by closing delays that sneak up on them without warning. An Industry Bottleneck Finally Addressed Enter Truss...

JiMMYBAR! Expands Creatine Market with Target Launch

JiMMYBAR! Breaks New Ground in Supplements You ever notice how some companies just know how to shake things up? Take JiMMYBAR!, for instance. The moment I read they’re making moves to get their Creatine + Protein bars into Target stores nationwide, starting October 4, I thought, “That’s one way to drag creatine out from the dusty tub and onto the shelves of...

ROKFORM’s Signal Card: A Wallet Tracker for All

The Gadget You Didn't Know You Needed Ever feel that momentary panic when your wallet seems to have vanished into thin air? ROKFORM's fresh offering, the Signal Card, tackles that heart-stopping moment head-on. They've taken the mundane act of misplacing your wallet and transformed it with their sleek, credit-card-sized tracker. This baby pairs seamlessly with Apple Find...

Dentistry.One Achieves HITRUST i1, Boosts Cybertrust

HITRUST i1 Certification: The Gold Standard in Security For a world increasingly reliant on digital infrastructure, cybersecurity certification is no longer just a badge of honor; it's a cornerstone of trust. Dentistry.One nailed this down by bagging that coveted HITRUST i1 certification. When folks talk about securing data, HITRUST might as well be speaking gospel. We're...

Charter Next Generation Unveils Gen 2 MDO-PE Films

Peering Into CNG's Latest Innovation Charter Next Generation (CNG) just threw down a hefty gauntlet with its launch of next-gen machine-direction-oriented polyethylene (MDO-PE) solutions. They're pushing the envelope on what recycle-ready packaging can do, folks. Let's not mince words—other players in the field better have their game faces on. This ain't just another...

Navigating Holiday Sweets: Healthy Balancing Acts

In the middle of the sweet madness that is the holiday season, Crispy Green and Dr. Nicole Avena are playing guide to families drowning in sugar. This isn't just a once-a-year Halloween headache; we're starting that sugar spiral early and letting it ride until the New Year approaches. It's an all-hands-on-deck situation if families want to dodge that sugar overload. Why...

Skandia's Soundproofing Kit Expands to Brazil's Skies

Soundproofing Takes Off in Brazil Skandia has just pulled off a neat trick, earning the nod from Brazil's National Civil Aviation Agency (ANAC) for their King Air soundproofing kit. That means quieter skies ahead for operators of the King Air 200 and 300 series in Brazil. This is no small feat, folks; it's like finally getting that coveted backstage pass after years of...

TA Services Strengthens U.S.-Mexico Freight Operations

TA Services Moves Boldly Across Borders If ever there was a time to play the logistics chessboard like a champ, it's now, and TA Services just slammed the board with a solid move. They've grabbed Carmen Pacheco Transportation and Interload Forwarding, two family-run operations with some real muscle in North American logistics. This isn't a small-time maneuver; they've...

Cala Launches Game-Changer Wearable for Tremor Relief

Breaking New Ground in Neuromodulation Medical tech's on a roll, and Cala Health just hopped on the fast track with their latest launch—the Cala kIQ Plus System. This bad boy is aiming to offer relief for those grappling with hand tremors, thanks to its FDA clearance and a host of new features. It's the first of its kind, combining multiple therapy modes with an...

Epic Political Thriller Explores Humanity's Future

Adams' Provocative Debut Asks Timeless Questions Sometimes life throws a philosophical curveball, and that's exactly what John C. Adams has done with his debut novel, The Third Phase. This isn't your average political yarn—it's an intricate tapestry intertwining political intrigue, deep spiritual inquiry, and hearty doses of classic philosophy. A Whirlwind Journey...